Analysis · Distribution · Part 1 of 4
A technology vendor pitching into insurance distribution is being asked three different questions by three different audiences. Most pitches answer one of them — and not always the right one first.
The most common outcome of a technology pitch into insurance is not rejection. It is polite interest that goes nowhere. The meeting was constructive, the technology was well received, follow-up was promised — and then nothing happens. This is rarely a sign that the proposition was weak. More often, it is a sign that the pitch answered a question the audience had not yet asked, while leaving the question they were actually asking unaddressed.
The question before the question
Before any evaluation begins, an underwriter, broker, or risk manager makes an almost instant classification: what kind of thing is this? That classification determines which mental category the proposition is filed under — and every subsequent claim is then judged against the assumptions that category carries, including its assumed cost, its assumed value, and its assumed relevance to underwriting.
This matters most for genuinely new categories of risk technology, where the capability may be materially different from anything the audience has previously evaluated, but the framing allows it to be mistaken for something familiar and lower-value. Predictive, address-level flood modelling can be heard as "a weather alert service." A computer-vision system trained to detect near-miss behaviour on a factory floor can be heard as "a security camera with extra software." Once filed under the cheaper category, the proposition is evaluated against criteria it was never trying to meet — and the rest of the pitch, however strong, is fighting the wrong reference point.
Key insight
Adjacent-category confusion is a framing failure, not a comprehension failure. The audience understood the pitch perfectly — they understood it as the wrong thing.
Three questions, three audiences, three timelines
Once the category is correctly identified, three distinct questions remain — and they are rarely asked by the same person, in the same room, at the same time.
Why this technology. Does this category of intervention measurably change loss frequency or severity, and is that effect evidenced in a form underwriting can act on? This is a question about the technology in general, not about any single vendor. It is typically put — explicitly or implicitly — by underwriting and risk engineering functions, and it is answerable even for an entirely new category, because it concerns what this kind of intervention can plausibly do.
Why us. Given the category is accepted, why this vendor over the alternatives — on data quality, integration, commercial terms, regulatory standing, or existing partnerships? This is a vendor-selection question, typically put by brokers, MGAs, and distribution partners. It has no traction until the category question has been resolved; differentiation only matters once there is something to be differentiated within.
Why now. What has changed — regulatory shift, claims environment, market conditions, competitor activity — that moves this from "interesting, revisit later" to "this belongs on the agenda this cycle"? This is often the question that converts interest into action, and it is the one most frequently omitted altogether.
A pitch that answers "why us" before "why this" has been accepted reads as marketing, because in that context, it is. A pitch that answers "why this" persuasively but never reaches "why now" generates agreement without urgency — and agreement without urgency rarely survives the next quarter's priorities.
Category maturity changes which question is hardest
The sequencing above holds regardless of category, but which question represents the real obstacle depends heavily on how established that category already is.
For a genuinely new category, "why this" is the binding constraint. No one has yet decided that this type of intervention belongs in the underwriting conversation at all, and that decision has to be won before anything else can proceed. The advantage of this position is that, once won, there is no incumbent to be compared against — the vendor that establishes the category often becomes its reference point.
For an established category — telematics is the clearest example — "why this" is effectively pre-answered. No one needs convincing that driving behaviour data is relevant to motor risk; the market decided that years ago. This sounds like an easier starting position, and in one sense it is. But it shifts the entire weight onto "why us," and that question is harder than it first appears, because the bar is not "is this credible" but "is this meaningfully better than what underwriters and brokers have already seen."
This is where the established-category trap appears. Without sharp differentiation, a vendor in a mature category does not inherit the category's legitimacy — they inherit its commodity floor. "We've seen this before" becomes the operative response, and the proposition is absorbed into a crowded field rather than positioned within it. The category that should have made the conversation easier instead becomes the reason the pitch is filed as "more of the same."
Key insight
New category, weak differentiation: the pitch never gets past "why this." Established category, weak differentiation: the pitch gets past "why this" for free — and then loses on "why us" without anyone quite saying so.
Diagnosing where a pitch actually stands
Most vendors can describe their technology fluently and their commercial terms confidently. Far fewer can say, with precision, which of these three questions their current pitch is actually answering, for which audience, and whether that is the question currently standing in their way. That diagnosis — not a better explanation of the technology — is usually the highest-value next step.
This is Part 1 of The Partnership Question, a four-part series. Part 2 sets out how to build the evidence behind each question. Part 3 examines the investor perspective. Part 4 addresses brokers and insurers evaluating risk technology partnerships.